Module

HAART and the Heart: Managing Cardiovascular Risk Through Antiretroviral Individualization

Source: Dyslipidemia and Other Cardiovascular Risk Factors in HIV: Causes, Clinical Significance, and Management Strategies

HAART and the Heart: Managing Cardiovascular Risk Through Antiretroviral Individualization


Faculty:

Stefan Mauss, MD, PhD
  • Stefan Mauss, MD, PhD

CME CREDIT INFORMATION

Release Date: 01/04/07

Expiration Date: 01/03/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.0 Nursing CE credit

Pharmacists: 1.0 contact hour (0.1 CEUs)

Status: Please log in to view status

Begin the Module

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the practical implications of the varying lipid effects of antiretroviral agents for treatment strategies using these agents
  • Review the impact of cardiovascular risk assessment on the choice of first-line antiretroviral regimens and the use of switch strategies
  • Describe the results of comparative studies of the impact of different agents and different switches between agents on cardiovascular risk factors

Topics covered include:

  • Introduction
  • Overview of Dyslipidemia Induced by Antiretrovirals
  • Effect of PIs on Lipid and Glucose Abnormalities
  • Effect of NNRTIs on Lipid and Glucose Abnormalities
  • Effect of NRTIs on Lipid and Glucose Abnormalities
  • Lipid Considerations of Antiretroviral Components When Initiating Therapy in Treatment-Naive Patients
  • Switching Antiretrovirals as a Strategy to Improve Dyslipidemia
  • Conclusion
  • Summary of Clinical Implications
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Medical Education Collaborative and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.